In an attempt to control the HIV/AIDS epidemic in Thailand, the Thai government decided to bypass the patents on anti-retroviral drugs (ARVs) by issuing compulsory
When a French teen becomes the target of police and is subjected to their interrogation while spending a night behind bars, one would imagine that
A Swiss pharmaceutical company, Novartis, sought to have the January 2006 decision to reject its patent application for the cancer drug imatinib mesylate (Gleevec) reversed
On August 27, 2007, the International Herald Tribune published an article by Dan Mitchell titled “Micropayments arrive on the Web.” This piece examined the evolution
In May of 2007 scientists at J. Craig Venter Institute filed a U.S. patent application on the world’s first synthetic living organism (U.S. Patent application
In January 2006, the Patent Office of Chennai rejected the patent application by Novartis for patent of the drug Gleevec (chemically known as imatinib mesylate).
